Definium Therapeutics, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx |
|---|---|---|---|
| FY2020 | $-23.6M | $-23.6M | — |
| FY2021 | $-45.8M | $-45.8M | — |
| FY2022 | $-50.1M | $-50.1M | — |
| FY2023 | $-64.4M | $-64.4M | — |
| FY2024 | $-79.1M | $-79.1M | — |
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx |
|---|---|---|---|
| FY2020 | $-23.6M | $-23.6M | — |
| FY2021 | $-45.8M | $-45.8M | — |
| FY2022 | $-50.1M | $-50.1M | — |
| FY2023 | $-64.4M | $-64.4M | — |
| FY2024 | $-79.1M | $-79.1M | — |